Business context and reporting period
Important entity mismatch: The supplied filing is Ares Acquisition Corporation II’s Form 10-K for the fiscal year ended December 31, 2023; it is not a Kodiak AI, Inc. filing. Ares Acquisition Corporation II was a blank-check SPAC, reported no operating business or operating revenue, and had not selected a business-combination target as of the filing.
The company completed its IPO on April 25, 2023, raising $500 million through 50 million units at $10 each. It states that its business-combination deadline is April 25, 2025. Public shares are redeemable in connection with a business combination or if the SPAC liquidates, subject to creditor claims and other terms.
Financial performance, cash flow and liquidity
| Metric | 2023 | 2022 |
|---|---|---|
| Operating revenue | None | None |
| General and administrative expense | $1.12 million | $3,542 |
| Trust-account investment income | $18.04 million | None |
| Net income (loss) | $16.92 million | $(3,542) |
| Operating cash flow | $(1.35) million | $0 |
2023 net income came from interest and investment income on trust assets, not operating activities. Reported basic and diluted earnings per share were $0.36 for both Class A and Class B shares. Operating cash at year-end was $1.91 million; working capital was $2.14 million.
The audited balance sheet reports $523.04 million in trust-account investments, $22.78 million in total liabilities, including $5.00 million of Sponsor overfunding loans and $17.50 million of deferred underwriting and advisory fees, and $522.94 million of Class A shares classified as temporary equity. The filing’s MD&A also gives a trust-account figure of $505.54 million, which conflicts with the audited balance sheet and other sections; the filing text does not explain this difference. The initial trust deposit was $505.00 million.
The company reported no long-term debt, lease obligations or off-balance-sheet arrangements. No margins are meaningful because it had no operating revenue. There were no working-capital loans outstanding at year-end. The company reported no dividends and does not expect to pay them before a business combination.
Material changes versus the prior comparable period
The comparison is affected by the company’s April 2023 IPO: 2022 activity consisted principally of formation costs, while 2023 included the IPO, trust investments and the related investment income. Consequently, the change from a small 2022 loss to 2023 net income is not evidence of operating growth. The company moved from no year-end cash or trust investments in 2022 to $1.91 million of operating cash and $523.04 million of trust assets in 2023.
Outlook, risks and unusual items
- Management expects sufficient working capital and Sponsor or affiliate borrowing capacity through the earlier of a business combination or one year from the filing. However, management states that failure to complete a business combination and the resulting mandatory liquidation raise substantial doubt about the company’s ability to continue as a going concern.
- The company had no identified target and no committed third-party financing. Redemptions, transaction costs, competition for targets, market conditions and financing availability could prevent or change a transaction; additional equity or debt could dilute shareholders or increase leverage.
- If no business combination is completed by April 25, 2025, public shares are to be redeemed from the trust, subject to taxes, liquidation costs and creditor claims. Warrants may expire worthless. The filing’s estimated liquidation value is approximately $10.10 per public share before trust income, but recovery is not assured.
- Potential conflicts include Ares-related allocation of opportunities, overlapping duties of directors and officers, Sponsor interests, and possible affiliated transactions. The Sponsor owns 12.5 million Class B shares, representing 20% of ordinary shares after the IPO, and may benefit differently from public shareholders.
- Key related-party and contingent amounts include $5.00 million of Sponsor overfunding loans, a $3.50 million deferred advisory fee payable only if a business combination closes, and $734,573 of service-provider fees contingent on closing.
- Management cites inflation, higher interest rates, financial-market instability, bank failures and geopolitical events as risks that could affect its search and transaction prospects. The filing also discusses new SEC SPAC rules and possible investment-company regulation.
- The auditor issued an unqualified opinion on the financial statements. Management concluded disclosure controls were effective at year-end; the filing did not include management’s internal-control assessment or an auditor attestation because of the newly public company transition period.
Important facts for investors to verify
- Confirm that this is the intended issuer: the filing names Ares Acquisition Corporation II, not Kodiak AI, Inc.
- Reconcile the trust-account balance: $523.04 million in the audited balance sheet versus $505.54 million in one MD&A passage.
- Confirm the business-combination deadline, any subsequent extensions or transaction announcements, and the amount available after any redemptions, taxes and claims.
- Review the Sponsor’s loans, promote and warrant terms, deferred fees, contingent fees, and potential dilution in any proposed transaction.
- Assess the company’s limited cash outside the trust, reliance on Sponsor funding, going-concern disclosure, and the risk that public warrants become worthless if no deal closes.